Reduced GSH (Antioxidant Power) GSH is the active form of glutathione and is responsible for its antioxidant properties
Calls BPC-157 "the Wild West" promising but no human RCTs 39% lean mass loss concern from STEP 1 trial advocates resistance training + high protein alongside GLP-1 Clinical prescribing perspective on GLP-1 agonists Protocols shown here are based on publicly disclosed information from Peter Attia
References Ibrahim MA, Mohammed SA, Elhabak DM (2021) Role of KLF2: new insight in inflammatory acne pathogenesis
Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ
The weight loss potential of semaglutide GLP-1 injections typically falls within the 15-20% range of initial body weight, with outcomes varying based on a few things like the weight youre starting at, metabolism, compliance with the regimen, dietary habits, exercise routine, and overall health condition
Route of Administration: IV/IM
